People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Huya Bioscience International, LLC | — | Biotechnology | Series C | $60.6M | $2.0B | 2013 |
Derek M. Winstanly at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Derek M. Winstanly on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mireille Gillings | 1 | 2 |
| Sabrina Martucci Johnson | 1 | 2 |
| Clement M. Gingras | 1 | 1 |
| Robert M. Haimsohn | 1 | 1 |
| Michael M. Mortimer | 1 | 1 |
| John M. Sharp | 1 | 1 |
| Derek M Winstanley | 1 | 1 |
| Mireille Gingras | 1 | 1 |
| Clement Gingras | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.